Follow
Troels Koch
Troels Koch
CTO Skorpio
No verified email
Title
Cited by
Cited by
Year
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
J Elmén, H Thonberg, K Ljungberg, M Frieden, M Westergaard, Y Xu, ...
Nucleic acids research 33 (1), 439-447, 2005
8112005
Silencing of microRNA families by seed-targeting tiny LNAs
S Obad, CO dos Santos, A Petri, M Heidenblad, O Broom, C Ruse, C Fu, ...
Nature genetics 43 (4), 371-378, 2011
7522011
Antisense drug technology: principles, strategies, and applications
ST Crooke
CRC press, 2007
6242007
Solid‐phase synthesis of peptide nucleic acids
L Christensen, R Fitzpatrick, B Gildea, KH Petersen, HF Hansen, T Koch, ...
Journal of peptide science: an official publication of the European Peptide …, 1995
4911995
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
CA Stein, JB Hansen, J Lai, SJ Wu, A Voskresenskiy, A H⊘ g, J Worm, ...
Nucleic acids research 38 (1), e3-e3, 2010
4162010
Peptide nucleic acids: protocols and applications
PE Nielsen
Garland Science, 2004
3962004
Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
EM Straarup, N Fisker, M Hedtjärn, MW Lindholm, C Rosenbohm, ...
Nucleic acids research 38 (20), 7100-7111, 2010
2802010
PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates
MW Lindholm, J Elmén, N Fisker, HF Hansen, R Persson, MR Møller, ...
Molecular therapy 20 (2), 376-381, 2012
2162012
Locked nucleic acid: modality, diversity, and drug discovery
PH Hagedorn, R Persson, ED Funder, N Albæk, SL Diemer, DJ Hansen, ...
Drug Discovery Today 23 (1), 101-114, 2018
2082018
Expanding the design horizon of antisense oligonucleotides with alpha‐l‐LNA
M Frieden, SM Christensen, ND Mikkelsen, C Rosenbohm, CA Thrue, ...
Nucleic acids research 31 (21), 6365-6372, 2003
1712003
Stopped-flow kinetics of locked nucleic acid (LNA)–oligonucleotide duplex formation: studies of LNA–DNA and DNA–DNA interactions
U CHRISTENSEN, N JACOBSEN, VK RAJWANSHI, J WENGEL, T KOCH
Biochemical Journal 354 (3), 481-484, 2001
1402001
Detection of the factor V Leiden mutation by direct allele-specific hybridization of PCR amplicons to photoimmobilized locked nucleic acids
H Ørum, MH Jakobsen, T Koch, J Vuust, MB Borre
Clinical chemistry 45 (11), 1898-1905, 1999
1381999
Improvements in automated PNA synthesis using Boc/Z monomers
T Koch, HF HANSEN, P ANDERSEN, T LARSEN, HG BATZ, K OTTESON, ...
The Journal of peptide research 49 (1), 80-88, 1997
1281997
Biological activity and biotechnological aspects of locked nucleic acids
KE Lundin, T Højland, BR Hansen, R Persson, JB Bramsen, J Kjems, ...
Advances in genetics 82, 47-107, 2013
1232013
SPC3042: a proapoptotic survivin inhibitor
JB Hansen, N Fisker, M Westergaard, LS Kjærulff, HF Hansen, CA Thrue, ...
Molecular cancer therapeutics 7 (9), 2736-2745, 2008
1212008
Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe
F Lamers, I Van Der Ploeg, L Schild, ME Ebus, J Koster, BR Hansen, ...
Endocrine Related Cancer 18 (6), 657, 2011
1092011
On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti‐H‐Ras antisense oligonucleotide
K Fluiter, M Frieden, J Vreijling, C Rosenbohm, MB De Wissel, ...
ChemBioChem 6 (6), 1104-1109, 2005
1062005
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern
PH Hagedorn, V Yakimov, S Ottosen, S Kammler, NF Nielsen, AM Høg, ...
nucleic acid therapeutics 23 (5), 302-310, 2013
1032013
Targeting RNA with conformationally restricted oligonucleotides
P Herdewijn
Liebigs Annalen 1996 (9), 1337-1348, 1996
1031996
Nuclease stability of LNA oligonucleotides and LNA-DNA chimeras
M Frieden, HF Hansen, T Koch
Nucleosides, Nucleotides and Nucleic Acids 22 (5-8), 1041-1043, 2003
952003
The system can't perform the operation now. Try again later.
Articles 1–20